Logo - International Journal of Pharmaceutical Compounding

Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration

Author(s):  Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel

Issue:  Jan/Feb 2009 - Compounding for Pediatrics
View All Articles in Issue

Abstract:  Palonosetron hydrochloride is a longer-acting, selective 5-HT3 receptor antagonist that has been approved for prevention of chemotherapy-induced nausea and vomiting and is being evaluated for prevention of postoperative nausea and vomiting. The objective of this study was to evaluate the physical and chemical stability of palonosetron hydrochloride 50 mcg/mL when mixed with undiluted propofol 1% during simulated Y-site administration. Duplicate samples of this mixture were tested. Samples were stored and evaluated for up to 4 hours at room temperature. Physical stability was assessed by visual inspection. Chemical stability was assessed by high-performance liquid chromatographic analysis. All of the admixtures were opaque white when viewed in normal fl uorescent room light and when viewed with a Tyndall beam. After centrifugation, no evidence of precipitation was found. The drug concentrations were essentially unchanged in all of the samples throughout the study. Palonosetron hydrochloride is physically and c

Related Keywords: stability, compatibility, propofol, chemotherapy, surgery, Lawrence A. Trissel, BS, RPh, FASHP, Craig Trusley, PharmD, MS, Thomas C. Kupiec, PhD, Michel Ben, MS, palonosetron hydrochloride, selective 5-HT3 receptor antagonist, nausea, vomiting, prevention, parenteral administration, intravenous infusion, drug admixtures

Related Categories: GASTROENTEROLOGY, PARENTERALS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=2901

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products